| 2025-12-11 |
详情>>
内部人交易：
Telling Fred股份减少210.00股
|
| 2025-11-07 |
详情>>
股本变动：
变动后总股本416.82万股
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-5.16美元,归母净利润-755.56万美元,同比去年增长-4.67%
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益-6.62美元,归母净利润-448.9万美元,同比去年增长5.61%
|
| 2025-07-01 |
复牌提示：
2025-07-01 08:02:09 停牌，复牌日期 2025-07-01 08:50:00
|
| 2025-06-03 |
详情>>
拆分方案：
每30.0000合并分成1.0000股
|
| 2025-05-09 |
详情>>
业绩披露：
2025年一季报每股收益-0.12美元,归母净利润-221.7万美元,同比去年增长9.54%
|
| 2025-04-01 |
股东大会：
将于2025-05-02召开股东大会
会议内容 ▼▲
- 1.To elect five Directors of the Company to serve until the next Annual Meeting of Shareholders (“Proposal 1”);
2.To conduct a non-binding advisory vote on the desired frequency of a non-binding advisory vote on executive compensation (the “Frequency of Voting for Executive Compensation Proposal” or “Proposal 2”);
3.To conduct a non-binding advisory vote on executive compensation (the “Executive Compensation Proposal” or “Proposal 3”);
4.To approve a proposal to authorize the Company’s Board of Directors (the “Board”), in its discretion at any time within one year after shareholder approval is obtained, to effect a reverse stock split (the “Reverse Stock Split”) of then-outstanding shares of the Company’s Common Stock, at a ratio of not less than one-for-five (1:5) and not greater than one-for-fifty (1:50), with the exact ratio to be determined by the Company’s Board and included in a public announcement (the “Reverse Stock Split Proposal” or “Proposal 4”);
5.To approve an amendment to the Company’s Articles of Incorporation, as amended, to increase the Company’s authorized shares of common stock to 350,000,000 in the event a reverse stock split of our common stock is effectuated prior to approval of the Reverse Stock Split Proposal (the “Increase Authorized Shares Proposal” or “Proposal 5”);
6.To approve an amendment to the Company’s 2021 Equity Incentive Plan, as amended (the “2021 Equity Incentive Plan”), to increase the number of common shares available for issuance under the 2021 Equity Incentive Plan from 3,166,667 shares of Common Stock, as reduced by any Reverse Stock Split, to 3,166,667 shares of Common Stock after the implementation and contingent on the effectuation of the Reverse Stock Split (the “Incentive Plan Increase Proposal” or “Proposal 6”);
7.To ratify the selection of Cherry Bekaert LLP as the Company’s independent auditors for the year ending December 31, 2025 “Proposal 7”);
8.To approve the adjournment of the Annual Meeting in the event that the number of shares of Common Stock and Series G Mirroring Preferred Stock present or represented by proxy at the Annual Meeting and voting “FOR” the adoption of Proposal 4 or Proposal 5 are insufficient (the “Adjournment Proposal” or “Proposal 8”);
9.To transact such other business as may properly come before the Annual Meeting.
|
| 2025-03-14 |
详情>>
业绩披露：
2024年年报每股收益-1.6美元,归母净利润-1056.79万美元,同比去年增长48.84%
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.49美元,归母净利润-721.88万美元,同比去年增长8.72%
|
| 2024-10-31 |
股东大会：
将于2024-12-11召开股东大会
会议内容 ▼▲
- 1.To elect six Directors of the Company to serve until the next Annual Meeting of Shareholders (“Proposal 1”);
2.To conduct a non-binding advisory vote on executive compensation (the “Executive Compensation Proposal” or “Proposal 2”);
3.To approve an amendment to the Company’s 2021 Equity Incentive Plan, as amended (the “2021 Equity Incentive Plan”), to increase the number of common shares available for issuance under the 2021 Equity Incentive Plan from 1,166,667 shares of Common Stock to 3,166,667 shares of Common Stock (the “Incentive Plan Increase Proposal” or “Proposal 3”);
4.To ratify the selection of Cherry Bekaert LLP as the Company’s independent auditors for the year ending December 31, 2024 “Proposal 4”);
5.To transact such other business as may properly come before the Annual Meeting.
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益-1.19美元,归母净利润-475.59万美元,同比去年增长19.33%
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.7美元,归母净利润-245.08万美元,同比去年增长13.85%
|
| 2024-03-29 |
详情>>
业绩披露：
2023年年报每股收益-9.18美元,归母净利润-2065.57万美元,同比去年增长-44.56%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-3.7美元,归母净利润-790.83万美元,同比去年增长34.37%
|
| 2023-10-30 |
股东大会：
将于2023-12-14召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) Directors of the Company to serve until the next Annual Meeting of Shareholders (“Proposal 1”);
2.To conduct a non-binding advisory vote on executive compensation (the “Executive Compensation Proposal” or “Proposal 2”);
3.To approve the adoption of an amendment to our Amended and Restated Articles of Incorporation to increase the number of authorized shares of our Common Stock from 4,166,666 shares of Common Stock to 350,000,000 shares of Common Stock (the “Increase in Authorized Common Stock Proposal” or “Proposal 3”);
4.To approve the adjournment of the Annual Meeting in the event that the number of shares of Common Stock and Series E Mirroring Preferred Stock present or represented by proxy at the Annual Meeting and voting “FOR” the adoption of Proposal 3 are insufficient (the “Adjournment Proposal” or “Proposal 4”).
5.To approve, in accordance with NYSE American Company Guide Section 712(b), the issuance of the Common Stock upon conversion of the Company’s Series F Convertible Preferred Stock, par value $0.0001 per share, which shares of Series F Convertible Preferred Stock are issuable upon the closing of the Asset Purchase Agreement between the Company and Odyssey Health, Inc. f/k/a Odyssey Group International, Inc., a Nevada corporation (“Odyssey”) dated October 4, 2023(the “Preferred Conversion Proposal” or “Proposal 5”);
6.To approve an amendment to the Company’s 2021 Equity Incentive Plan, as amended (the “2021 Equity Incentive Plan”), to increase the number of common shares available for issuance under the 2021 Equity Incentive Plan from 166,667 shares of Common Stock to 1,666,667 shares of Common Stock (the “Incentive Plan Increase Proposal” or “Proposal 6”);
7.To ratify the selection of Cherry Bekaert LLP as the Company’s independent auditors for the year ending December 31, 2023 “Proposal 7”);
8.To transact such other business as may properly come before the Annual Meeting.
|
| 2023-08-11 |
详情>>
业绩披露：
2023年中报每股收益-2.91美元,归母净利润-589.54万美元,同比去年增长27.93%
|
| 2023-01-23 |
详情>>
拆分方案：
每60.0000合并分成1.0000股
|
| 2022-10-31 |
股东大会：
将于2022-12-16召开股东大会
会议内容 ▼▲
- 1.To elect five (5) Directors of the Company to serve until the next Annual Meeting of Shareholders;
2.To conduct a non-binding advisory vote on executive compensation;
3.To approve the adoption of an amendment to our Amended and Restated Articles of Incorporation which will increase the number of authorized shares of our Common Stock from 250,000,000 shares of Common Stock to 350,000,000 shares of Common Stock;
4.To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2022;
5.To transact such other business as may properly come before the Annual Meeting.
|
| 2021-10-13 |
股东大会：
将于2021-11-22召开股东大会
会议内容 ▼▲
- 1.To elect five (5) Directors of the Company to serve until the next Annual Meeting of Shareholders;
2.To conduct a non-binding advisory vote on executive compensation;
3.To approve the adoption of an amendment to our Amended and Restated Articles of Incorporation which will provide a reduced quorum requirement of one-third (1/3) of shares entitled to be cast, represented in person or by a proxy, in order to constitute a meeting of shareholders;
4.To approve the adoption of an amendment to our Amended and Restated Articles of Incorporation which will increase the number of authorized shares of our Common Stock from 200,000,000 shares of Common Stock to 250,000,000 shares of Common Stock;
5.To approve the Company’s 2021 Equity Incentive Plan;
6.To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2021;
7.To transact such other business as may properly come before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-24 |
股东大会：
将于2021-06-30召开股东大会
会议内容 ▼▲
- 1.To elect five (5) Directors of the Company to serve until the next Annual Meeting of Shareholders;
2.To conduct a non-binding advisory vote on executive compensation;
3.To approve the adoption of an amendment to our Amended and Restated Articles of Incorporation which will increase the number of authorized shares of our Common Stock from 200,000,000 shares of Common Stock to 250,000,000 shares of Common Stock;
4.To approve the Company’s 2021 Equity Incentive Plan;
5.To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2021;
6.To transact such other business as may properly come before the Annual Meeting.
|
| 2020-07-13 |
股东大会：
将于2020-08-21召开股东大会
会议内容 ▼▲
- 1.To elect six (6) Directors of the Company to serve until the next Annual Meeting of Shareholders;
2.To conduct a non-binding advisory vote on executive compensation;
3.To approve the issuance of up to 9,200,000 shares of Common Stock upon the exercise of the NTI Transaction Warrants;
4.To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2020;
5.To transact such other business as may properly come before the Annual Meeting.
|
| 2019-05-16 |
股东大会：
将于2019-06-20召开股东大会
会议内容 ▼▲
- 1.To elect five (5) Directors of the Company to serve until the next annual meeting of shareholders;
2.To conduct a non-binding advisory vote on the desired frequency of a non-binding advisory vote on executive compensation;
3.To conduct a non-binding advisory vote on executive compensation;
4.To ratify the 2018 amendment to the Company’s 2012 Equity Incentive Plan, as amended (the “2012 Equity Incentive Plan”) which amendment was previously approved by shareholders at the Company’s 2017 Annual Meeting, and increased the number of common shares available for issuance under the 2012 Equity Incentive Plan by 1,500,000 shares;
5.To approve an amendment to the Company’s 2012 Equity Incentive Plan to increase the number of common shares available for issuance by 6,000,000 shares;
6.To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2019;
7.To transact such other business as may properly come before the Annual Meeting.
|
| 2018-05-17 |
股东大会：
将于2018-06-22召开股东大会
会议内容 ▼▲
- 1.To re-elect five (5) Directors of the Company to serve until the next annual meeting of shareholders;
2.To conduct a non-binding advisory vote on executive compensation;
3.To approve the adoption of an amendment to our Amended and Restated Articles of Incorporation which will increase the number of authorized shares of our Common Stock from 45,000,000 shares of Common Stock to 200,000,000 shares of Common Stock;
4.To approve the amendment of our 2012 Equity Incentive Plan (the “2012 Incentive Plan”) to increase the number of common shares available for issuance under the 2012 Incentive Plan by 1,500,000 shares;
5.To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2018;
6.To transact such other business as may properly come before the Annual Meeting.
|
| 2018-01-08 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2017-03-29 |
股东大会：
将于2017-05-04召开股东大会
会议内容 ▼▲
- 1. To re-elect five (5) Directors of the Company to serve until the next annual meeting of shareholders;
2. To conduct a non-binding advisory vote on executive compensation;
3. To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2017;
4. To approve the amendment of our 2012 Equity Incentive Plan (the “2012 Incentive Plan”) to increase the number of common shares available for issuance under the 2012 Incentive Plan by 1,500,000 shares;
5. To transact such other business as may properly come before the Annual Meeting.
|
| 2016-07-15 |
股东大会：
将于2016-08-25召开股东大会
会议内容 ▼▲
- 1. To re-elect five (5) Directors of the Company to serve until the next annual meeting of shareholders;
2. To conduct a non-binding advisory vote on executive compensation;
3. To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2016
4. To transact such other business as may properly come before the Annual Meeting.
|
| 2015-06-04 |
股东大会：
将于2015-07-16召开股东大会
会议内容 ▼▲
- (i)To re-elect five (5) Directors of the Company to serve until the next annual meeting of shareholders;
(ii)To conduct a non-binding advisory vote on executive compensation;
(iii)To ratify the selection of Mayer Hoffman McCann P.C. as the Company’s independent auditors for the year ending December 31, 2015;
(iv)To transact such other business as may properly come before the Annual Meeting.
|